AI assistant
Sending…
DEXCOM INC — Director's Dealing 2018
Mar 14, 2018
30198_dirs_2018-03-14_cc49d916-500e-4191-bdcc-03953491afdd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2018-03-12
Reporting Person: ACE HEATHER S (SVP Human Resources)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-03-12 | Common Stock | D | 2627 | $60.7306 | Disposed | 74232 | Direct |
Footnotes
F1: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.
F2: Included in this number are 65,306 unvested restricted stock units, 30,093 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 14,588 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 20,625 of which were granted on August 22, 2016 and shall vest through August 22, 2020.
More from DEXCOM INC
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 15
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 17